Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Congress Asset Management Co.

Congress Asset Management Co. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% in the first quarter, Holdings Channel.com reports. The institutional investor owned 312,708 shares of the medical equipment provider’s stock after purchasing an additional 5,078 shares during the quarter. Intuitive Surgical comprises about 1.2% of Congress Asset Management Co.’s holdings, making the stock its 15th largest position. Congress Asset Management Co.’s holdings in Intuitive Surgical were worth $154,875,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of ISRG. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $25,000. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. Global Financial Private Client LLC grew its stake in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 38 shares in the last quarter. BankPlus Trust Department acquired a new stake in Intuitive Surgical during the 4th quarter valued at approximately $28,000. Finally, Hurley Capital LLC acquired a new stake in Intuitive Surgical during the 4th quarter valued at approximately $28,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.2%

Shares of ISRG opened at $557.08 on Friday. The firm has a market cap of $199.67 billion, a price-to-earnings ratio of 86.91, a PEG ratio of 5.85 and a beta of 1.67. The stock has a 50 day moving average of $521.99 and a 200-day moving average of $539.26. Intuitive Surgical, Inc. has a 52 week low of $413.52 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter last year, the firm earned $1.50 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on ISRG shares. Barclays lowered their price objective on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research note on Thursday, April 24th. Piper Sandler lowered their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating for the company in a research note on Wednesday, April 23rd. Citigroup restated a “buy” rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Truist Financial lowered their price objective on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. Finally, Robert W. Baird lowered their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a research note on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $596.05.

Insider Buying and Selling

In related news, EVP Gary Loeb sold 1,700 shares of the firm’s stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the sale, the executive vice president now owns 2,245 shares of the company’s stock, valued at approximately $1,152,089.10. This trade represents a 43.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. The trade was a 60.72% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 25,443 shares of company stock valued at $12,692,195. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.